Reconsideration of maternal serological testing for predicting congenital CMV infection.
Yue HuangJiabao TangHuan YuQiaoqiao SongMengling HaoHan WangJunxian LiuYue DongMufeng LiangSijie ZhuangCaihong LiJiangding WangCaihong LiangYingying SuTingdong LiTing WuShengxiang GeJun ZhangNing-Shao XiaPublished in: The Journal of infectious diseases (2023)
The value of current maternal CMV serological testing in regions with high seropositivity rates is very limited and should be reconsidered. The detection of DNAemia would be helpful in assessing the risk of intrauterine transmission.